NCT03243669 is a NA clinical trial of High-definition in Colonic Adenoma, sponsored by Universitaire Ziekenhuizen KU Leuven.

Who is sponsoring NCT03243669?

NCT03243669 is sponsored by Universitaire Ziekenhuizen KU Leuven.

What drugs are being tested in NCT03243669?

Interventions in NCT03243669: High-definition, Virtual chromoendoscopy, Standard.

What condition does NCT03243669 study?

NCT03243669 studies Colonic Adenoma.

Is NCT03243669 still recruiting?

NCT03243669 is currently completed. Last updated 27 January 2023.

Last reviewed 2023-01-27 · How we verify

NCT03243669

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

High Definition Endoscopy and Virtual Chromoendoscopy Versus Standard Resolution Endoscopy in Detection of Colon Polyps

Completed NA Last updated 27 January 2023

What this trial tests

NA trial testing High-definition in Colonic Adenoma in 2,146 participants. Completed in 31 December 2014.

Timeline

1 December 2010

Primary endpoint
30 June 2014

31 December 2014

Quick facts

Lead sponsor	Universitaire Ziekenhuizen KU Leuven
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	diagnostic
Enrollment	2,146
Start date	1 December 2010
Primary completion	30 June 2014
Estimated completion	31 December 2014
Sites	1 location across Belgium

Drugs / interventions tested

High-definition
Virtual chromoendoscopy
Standard

Conditions studied

Colonic Adenoma — all drugs for Colonic Adenoma →

Sponsor

Universitaire Ziekenhuizen KU Leuven — full company profile →

Who can join

18 and older, any sex, with Colonic Adenoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Over the last years a number of new endoscopic imaging modalities have been introduced (high-definition and virtual chromoendoscopy). Given the theoretical advantage of these new imaging techniques, the investigators aimed to investigate their use for the detection of polyps during colonoscopy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Universitaire Ziekenhuizen KU Leuven trials

Trials by the same sponsor.

NCT06831955 — LifEStyle Intervention to Enhance Efficacy of Neoadjuvant Therapy in Patients With Triple Negative Breast Cancer · Phase 2 · recruiting
NCT07356505 — Efficacy and Safety of Micra AV2 Transcatheter Pacing System · NA · recruiting
NCT07286968 — Gastro-Intestinal Digestion and Physiology After Bariatric Surgery · recruiting
NCT06962137 — Phase II RAINSPOT: Zolbetuximab-Paclitaxel-Ramucirumab for CLDN18.2 Positive Gastro-esophageal Cancer · Phase 2 · recruiting
NCT07270536 — Accelerated Pacing and Cardiac Filling Pressures During Exercise in Patients With Heart Failure With Preserved Ejection · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03243669 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universitaire Ziekenhuizen KU Leuven
Last refreshed: 27 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03243669.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing